Lead Plaintiff Deadline: November 26, 2018
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
(1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in during the relevant time frame, you have until November 26, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
In order to be included in the lawsuit, you must have incurred a loss on shares of purchased or acquired during the class period listed above.